Phase 1 Weekly Dosing of SCH 727965 in Patients With Advanced Cancer (Study P04629AM6)

Clinical trial NCT00871663 · COMPLETED

Trial details

NCT number: NCT00871663
Sponsor: Merck Sharp & Dohme LLC
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Solid Tumors Lymphoma, Non-Hodgkin Multiple Myeloma Leukemia, Lymphocytic, Chronic. B-Cell

Start date: 2006-08-01
Primary completion: 2012-10-01
Enrollment: 123

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.